Literature DB >> 21358642

MHCI negatively regulates synapse density during the establishment of cortical connections.

Marian W Glynn1, Bradford M Elmer, Paula A Garay, Xiao-Bo Liu, Leigh A Needleman, Faten El-Sabeawy, A Kimberley McAllister.   

Abstract

Major histocompatibility complex class I (MHCI) molecules modulate activity-dependent refinement and plasticity. We found that MHCI also negatively regulates the density and function of cortical synapses during their initial establishment both in vitro and in vivo. MHCI molecules are expressed on cortical neurons before and during synaptogenesis. In vitro, decreasing surface MHCI (sMHCI) on neurons increased glutamatergic and GABAergic synapse density, whereas overexpression decreased it. In vivo, synapse density was higher throughout development in β2m(-/-) mice. MHCI also negatively regulated the strength of excitatory, but not inhibitory, synapses and controlled the balance of excitation and inhibition onto cortical neurons. sMHCI levels were modulated by activity and were necessary for activity to negatively regulate glutamatergic synapse density. Finally, acute changes in sMHCI and activity altered synapse density exclusively during early postnatal development. These results identify a previously unknown function for immune proteins in the negative regulation of the initial establishment and function of cortical connections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358642      PMCID: PMC3251641          DOI: 10.1038/nn.2764

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  47 in total

1.  Functional requirement for class I MHC in CNS development and plasticity.

Authors:  G S Huh; L M Boulanger; H Du; P A Riquelme; T M Brotz; C J Shatz
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

2.  Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness.

Authors:  Paul H Patterson
Journal:  Curr Opin Neurobiol       Date:  2002-02       Impact factor: 6.627

3.  Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.

Authors:  Elias T Spiliotis; Tsvetelina Pentcheva; Michael Edidin
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

Review 4.  Estimation of the number of synapses in the cerebral cortex: methodological considerations.

Authors:  J DeFelipe; P Marco; I Busturia; A Merchán-Pérez
Journal:  Cereb Cortex       Date:  1999 Oct-Nov       Impact factor: 5.357

5.  Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons.

Authors:  Juan Burrone; Michael O'Byrne; Venkatesh N Murthy
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

6.  Colocalization of multiple GABA(A) receptor subtypes with gephyrin at postsynaptic sites.

Authors:  M Sassoè-Pognetto; P Panzanelli; W Sieghart; J M Fritschy
Journal:  J Comp Neurol       Date:  2000-05-15       Impact factor: 3.215

Review 7.  Cytokine and growth factor involvement in schizophrenia--support for the developmental model.

Authors:  H Nawa; M Takahashi; P H Patterson
Journal:  Mol Psychiatry       Date:  2000-11       Impact factor: 15.992

8.  Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming.

Authors:  Frederique Varoqueaux; Albrecht Sigler; Jeong-Seop Rhee; Nils Brose; Carsten Enk; Kerstin Reim; Christian Rosenmund
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

9.  Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.

Authors:  Limin Shi; S Hossein Fatemi; Robert W Sidwell; Paul H Patterson
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

10.  EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation.

Authors:  Seth S Margolis; John Salogiannis; David M Lipton; Caleigh Mandel-Brehm; Zachary P Wills; Alan R Mardinly; Linda Hu; Paul L Greer; Jay B Bikoff; Hsin-Yi Henry Ho; Michael J Soskis; Mustafa Sahin; Michael E Greenberg
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

View more
  80 in total

1.  Lessons learned at the intersection of immunology and neuroscience.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease.

Authors:  Bradford M Elmer; Myka L Estes; Stephanie L Barrow; A Kimberley McAllister
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

3.  Spatial-Temporal Expression of Non-classical MHC Class I Molecules in the C57 Mouse Brain.

Authors:  Jiane Liu; Yuqing Shen; Mingli Li; Dan Lv; Aifeng Zhang; Yaqin Peng; Fengqin Miao; Jianqiong Zhang
Journal:  Neurochem Res       Date:  2015-06-04       Impact factor: 3.996

4.  Developmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb.

Authors:  Jaimie D Adelson; Richard W Sapp; Barbara K Brott; Hanmi Lee; Kazunari Miyamichi; Liqun Luo; Sarah Cheng; Maja Djurisic; Carla J Shatz
Journal:  Cereb Cortex       Date:  2014-10-14       Impact factor: 5.357

5.  Developmental expression and localization of MHC class I molecules in the human central nervous system.

Authors:  Aifeng Zhang; Hong Yu; Youji He; Yuqing Shen; Ying Zhang; Jiane Liu; Bo Fu; Dan Lv; Fengqin Miao; Jianqiong Zhang
Journal:  Exp Brain Res       Date:  2015-07-14       Impact factor: 1.972

Review 6.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

7.  MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling.

Authors:  Tracy J Dixon-Salazar; Lawrence Fourgeaud; Carolyn M Tyler; Julianna R Poole; Joseph J Park; Lisa M Boulanger
Journal:  J Neurosci       Date:  2014-08-27       Impact factor: 6.167

Review 8.  Maternal immune activation and abnormal brain development across CNS disorders.

Authors:  Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

9.  Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development.

Authors:  Xiao-Bo Liu; Jillian R Haney; Gloria Cantero; Jenna R Lambert; Marcos Otero-Garcia; Brian Truong; Andrea Gropman; Inma Cobos; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  JCI Insight       Date:  2019-09-05

Review 10.  Major histocompatibility complex I in brain development and schizophrenia.

Authors:  A Kimberley McAllister
Journal:  Biol Psychiatry       Date:  2013-10-10       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.